Verastem Inc
VSTMHealthcare·Biotechnology·USA·Small·NASD·Nov 13 • 7:45 AM ET
8.35-0.09 (-1.07%)
2026-11-13 13:53 CET
Market cap
$1.05B
Revenue, TTM
100.30 USD m
Net income, TTM
-178.90 USD m
Free cash flow, TTM
-159.57 USD m
EPS diluted, TTM
-1.85
Price
VSTM against its 20, 50 and 200-day averagesPatternshover a marker to name it
22.8% under the 52-week high of 10.82 on 26 Nov 2025. 52-week low 3.43 on 25 Jun 2026. Last 15 sessions, 32.8% high to low
Volume 0.01× normal · the line is the 50-bar volume average
Setup. RS line 75
CANSLIM 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 2 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Float: Under 100M; Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%
Profile
VSTM52-week range, 67% of the way up
3.4310.82
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
| Index | RUT |
|---|---|
| Employees | 102 |
| IPO | Jan 27, 2012 |
| Beta | 0.47 |
| ATR, 14d | 0.64 |
| Rel volume | 0.01 |
| Short float | 17.24% |
| Insider own | 9.46% |
| Inst own | 74.92% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $1.05B |
| Enterprise Value | 1.01B |
| Income | -178.90M |
| Sales | 100.30M |
| Book / share | 0.11 |
| Cash / share | 1.37 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 102 |
| IPO | Jan 27, 2012 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 10.49 |
| Price / book | 78.10 |
| Price / cash | 6.09 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 10.05 |
| Quick Ratio | 1.91 |
| Current Ratio | 1.93 |
| Debt / equity | 12.73 |
| Long-term debt / equity | 11.51 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -1.85 |
|---|---|
| Earnings next year | -2.04 |
| Earnings next quarter | -0.53 |
| Earnings this year | 34.71% |
| Earnings next year | -3.44% |
| Earnings growth, 5 years | 11.44% |
| Past earnings growth | 12.90% 10.63% |
| Past sales growth | - 10.80% |
| Earnings vs last year | 54.01% |
| Sales vs last year | 649.65% |
| Earnings vs last quarter | 45.19% |
| Sales vs last quarter | 113.59% |
| Earnings | Nov 05 AMC |
| Surprise | -56.45% -9.63% |
Ownership
| Insiders own | 9.46% |
|---|---|
| Insider trades | -0.62% |
| Institutions own | 74.92% |
| Institution trades | 7.93% |
| Return on assets | -88.02% |
| Return on equity | -471.16% |
| Return on capital | -141.64% |
| Gross Margin | 86.11% |
| Operating margin | -193.73% |
| Profit Margin | -178.38% |
| 20-day average | -10.66% |
| 50-day average | -1.64% |
| 200-day average | 32.60% |
Technical
| Shares out | 126.02M |
|---|---|
| Shares floating | 114.09M |
| Short / float | 17.24% |
| Short ratio | 5.76 |
| Short interest | 19.67M |
| 52-week high | 10.82 -22.8% |
| 52-week low | 3.43 +143.4% |
| Volatility | 8.55% 7.94% |
| Average range | 0.64 |
| Strength index | 43.24 |
| Market sensitivity | 0.47 |
| Relative volume | 0.01 |
| Avg Volume | 3.42M |
| Volume | 1,393 |
Performance
| Perf Week | -0.71% |
|---|---|
| Perf Month | -9.53% |
| Perf Quarter | 16.30% |
| Perf Half Y | 93.29% |
| Perf YTD | 8.16% |
| Perf Year | 2.96% |
| Perf 3Y | 30.88% |
| Perf 5Y | -77.84% |
| Perf 10Y | -44.33% |
| Recommendation | 1.00 |
| Target Price | 17.22 |
| Prev Close | 8.44 |
| Price | 8.35 |
| Change % | -1.07% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 17, 2026 | Initiated | Wolfe Research | Outperform | ||
| Mar 12, 2026 | Resumed | BTIG Research | Buy | $19 | +127.5% |
| Feb 04, 2026 | Initiated | H.C. Wainwright | Buy | $18 | +115.6% |
| Oct 16, 2025 | Resumed | Cantor Fitzgerald | Overweight | ||
| Apr 10, 2025 | Initiated | Jefferies | Buy | $15 | +79.6% |
| Mar 24, 2025 | Reiterated | H.C. Wainwright | Buy | $7 → $10 | +19.8% |
| Dec 31, 2024 | Reiterated | BTIG Research | Buy | $13 → $20 | +139.5% |
| Sep 30, 2024 | Initiated | Guggenheim | Buy | $13 | +55.7% |
| Nov 21, 2023 | Resumed | BTIG Research | Buy | $27 | +223.4% |
| Sep 27, 2023 | Initiated | B. Riley Securities | Buy | $21 | +151.5% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ERAS | Erasca Inc | 5.52B |
| RVMD | Revolution Medicines Inc | 38.50B |
| BBOT | BridgeBio Oncology Therapeutics Inc | 188.59M |
| IMRX | Immuneering Corp | 240.98M |
| CELC | Celcuity Inc | 3.14B |
| KURA | Kura Oncology Inc | 700.12M |
| ORIC | ORIC Pharmaceuticals Inc | 886.23M |
| ELVN | Enliven Therapeutics Inc | 3.56B |
| ZNTL | Zentalis Pharmaceuticals Inc | 164.94M |
| CRDF | Cardiff Oncology Inc | 56.60M |
Insider trading
latest 14 of 42| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Paterson Dan | President and CEO | Nov 03 '26 | Sale | 9.60 | 1,299 | 12,470 | 651,413 | Nov 05 07:53 PM |
| Paterson Dan | President and CEO | Oct 01 '26 | Sale | 8.00 | 44,121 | 352,968 | 652,712 | Oct 02 05:15 PM |
| Calkins Daniel | Chief Financial Officer | Oct 01 '26 | Sale | 8.00 | 2,566 | 20,528 | 123,781 | Oct 02 05:15 PM |
| Dan Paterson | Officer, Director | Oct 01 '26 | Proposed Sale | 8.00 | 44,121 | 353,047 | Oct 01 06:55 PM | |
| Calkins Daniel | Chief Financial Officer | Sep 21 '26 | Sale | 7.70 | 55 | 424 | 118,014 | Sep 23 08:10 PM |
| Paterson Dan | President and CEO | Aug 03 '26 | Sale | 5.81 | 1,302 | 7,565 | 589,940 | Aug 05 04:37 PM |
| Gagnon Robert E. | Director | Jul 23 '26 | Proposed Sale | 5.89 | 31,924 | 188,032 | Jul 23 04:32 PM | |
| Gagnon Robert E. | Director | Jun 25 '26 | Proposed Sale | 4.21 | 21,492 | 90,481 | Jun 25 04:01 PM | |
| Paterson Dan | President and CEO | Jun 22 '26 | Sale | 4.18 | 20,871 | 87,241 | 591,242 | Jun 24 04:45 PM |
| Calkins Daniel | Chief Financial Officer | Jun 22 '26 | Sale | 4.18 | 4,089 | 17,089 | 117,238 | Jun 24 04:44 PM |
| Dan Paterson | Officer, Director | Jun 22 '26 | Proposed Sale | 4.18 | 20,871 | 87,241 | Jun 22 07:50 PM | |
| Gagnon Robert E. | Director | May 27 '26 | Proposed Sale | 4.36 | 20,103 | 87,649 | May 27 04:47 PM | |
| Paterson Dan | President and CEO | May 04 '26 | Sale | 5.82 | 806 | 4,691 | 612,113 | May 06 04:01 PM |
| Paterson Dan | President and CEO | Feb 04 '26 | Sale | 6.69 | 970 | 6,489 | 612,919 | Feb 05 04:10 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| XBI | State Street SPDR S&P Biotech ETF | AUM: 10.59B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| BBP | Virtus Biotech ETF | AUM: 136.32M |
| FESM | Fidelity Enhanced Small Cap Core ETF | AUM: 6.90B |
| IDNA | iShares Genomics Immunology and Healthcare ETF | AUM: 352.11M |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
News
latest 14 of 200- Verastem Misses As Co-Pack Sales Stall, But VS-7375 Data And A $250 Million Raise Reset The Investment Case (Earnings Whispers) -10.34%
- Verastem: Q3 Earnings Snapshot (Associated Press)
- Verastem Oncology Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates (Business Wire)
- Verastem Oncology to Participate in Upcoming November Investor Conferences (Business Wire)
- Verastem Must Prove Its Commercial Rebound Is Real As G12D Hopes Lift The Stock (Earnings Whispers)
- Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026 (Business Wire) +9.23%
- VSTM Stock Clocks Best Day In 11 Months After Positive Cancer Drug Trial Update And Multiple Price-Target Hikes (Stocktwits) +19.71% -6.28%
- Verastems KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC (Clinical Trials Arena)
- Verastem cancer drug shows early promise in small study (BioPharma Dive)
- Verastem Is Getting a New CEO, $250 Million, and a Shot at Another Cancer Drug (Barrons.com)
- Verastem Has Positive Early Cancer Data And $250M In New Funding: What VSTM Investors Need To Know (Stocktwits)
- Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants (Business Wire)
- Verastem Oncology Announces Planned Chief Executive Officer Transition and Succession Plan (Business Wire)
- VS-7375 Demonstrates Robust Anti-Tumor Activity Across Advanced KRAS G12D-Mutant Cancers, Highlighted by 50% Confirmed ORR in 2L Pancreatic Ductal Adenocarcinoma and Two Complete Responses in 2L+ Disease (One Confirmed) (Business Wire)
Quarterly earnings
2026Q3 EPS -0.740 missed -0.473, from -1.350 a year earlier. Sales 24.01 missed 26.57, from 11.24 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-05 16:30 | -0.740 | -0.473 | -0.740 | 24.01 | 26.57 | EPS +56.4% · sales -9.6% | vs 2025Q3, year-ago quarter · EPS -45.2% · sales +113.6% | 9 EPS · 10 sales | Open -7.68% vs SPY +0.25%. Close -10.34% vs SPY +0.31% |
| 2026Q2ended 2026-06-30 | 2026-08-06 16:30 | -0.350 | -0.431 | -0.346 | 40.08 | 22.88 | EPS -18.7% · sales +75.2% | vs 2025Q2, year-ago quarter · EPS -10.3% · sales +1775.4% | 8 EPS · 9 sales | Open +12.52% vs SPY +0.32%. Close +14.04% vs SPY +0.61% |
| 2026Q1ended 2026-03-31 | 2026-05-07 16:30 | -0.370 | -0.465 | -0.372 | 18.67 | 21.43 | EPS -20.4% · sales -12.9% | vs 2025Q1, year-ago quarter · EPS -61.5% · sales +11569.4% | 8 EPS · 9 sales | Open -3.71% vs SPY +0.46%. Close -13.60% vs SPY +0.83% |
| 2025Q4ended 2025-12-31 | 2026-03-04 16:30 | -0.390 | -0.520 | -0.395 | 17.54 | 16.90 | EPS -25.0% · sales +3.7% | vs 2024Q4, year-ago quarter · EPS -70.7% · sales - | 7 EPS · 8 sales | Open +2.41% vs SPY -0.45%. Close +5.85% vs SPY -0.56% |
| 2025Q3ended 2025-09-30 | 2025-11-04 08:30 | -1.350 | -0.617 | -1.347 | 11.24 | 5.76 | EPS +118.9% · sales +95.3% | vs 2024Q3, year-ago quarter · EPS +125.0% · sales +16754.6% | 9 | Open -7.98% vs SPY -1.06%. Close -20.10% vs SPY -1.19% |
| 2025Q2ended 2025-06-30 | 2025-08-07 16:30 | -0.390 | -0.728 | -0.625 | 2.14 | 1.25 | EPS -46.4% · sales +71.1% | vs 2024Q2, year-ago quarter · EPS +25.8% · sales -78.6% | 9 EPS · 8 sales | Open -0.36% vs SPY +0.29%. Close +19.93% vs SPY +0.78% |
| 2025Q1ended 2025-03-31 | 2025-05-13 16:30 | -0.960 | -0.700 | -0.962 | 0.16 | 0.10 | EPS +37.1% · sales +60.0% | vs 2024Q1, year-ago quarter · EPS -23.8% · sales - | 9 EPS · 8 sales | Open -0.27% vs SPY +0.17%. Close -4.42% vs SPY +0.13% |
| 2024Q4ended 2024-12-31 | 2025-03-20 16:30 | -1.330 | -0.829 | -1.325 | 0.00 | 0.20 | EPS +60.5% · sales -100.0% | vs 2023Q4, year-ago quarter · EPS +30.4% · sales - | 8 EPS · 6 sales | Open -1.61% vs SPY -1.10%. Close -2.49% vs SPY -0.27% |
| 2024Q3ended 2024-09-30 | 2024-11-06 16:30 | -0.600 | -0.738 | -0.595 | 0.07 | 0.06 | EPS -18.7% · sales +16.8% | vs 2023Q3, year-ago quarter · EPS -20.0% · sales - | 9 EPS · 7 sales | Open -3.88% vs SPY +0.35%. Close -6.98% vs SPY +0.77% |
| 2024Q2ended 2024-06-30 | 2024-08-08 16:30 | -0.310 | -0.963 | -0.307 | 10.00 | 0.07 | EPS -67.8% · sales +14892.5% | vs 2023Q2, year-ago quarter · EPS -77.4% · sales - | 8 EPS · 6 sales | Open +6.25% vs SPY -0.16%. Close +4.91% vs SPY +0.44% |
| 2024Q1ended 2024-03-31 | 2024-05-09 16:30 | -1.260 | -1.031 | -1.262 | 0.00 | 0.00 | EPS +22.2% · sales - | vs 2023Q1, year-ago quarter · EPS +31.3% · sales - | 7 EPS · 5 sales | Open -1.43% vs SPY +0.32%. Close -0.59% vs SPY +0.13% |
| 2023Q4ended 2023-12-31 | 2024-03-14 16:30 | -1.020 | -0.611 | -1.021 | 0.00 | 7.12 | EPS +66.8% · sales -100.0% | vs 2022Q4, year-ago quarter · EPS +6.3% · sales - | 7 EPS · 5 sales | Open -4.86% vs SPY -0.92%. Close +4.76% vs SPY -0.99% |
| 2023Q3ended 2023-09-30 | 2023-11-08 16:30 | -0.750 | -0.843 | -0.747 | 0.00 | 0.03 | EPS -11.0% · sales -100.0% | vs 2022Q3, year-ago quarter · EPS -30.6% · sales - | 7 EPS · 6 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-08 16:30 | -1.370 | -1.043 | -1.369 | 0.00 | 0.02 | EPS +31.3% · sales -100.0% | vs 2022Q2, year-ago quarter · EPS -4.9% · sales - | 6 | - |
| 2023Q1ended 2023-03-31 | 2023-05-09 16:30 | -0.960 | -1.000 | -0.940 | 0.00 | 0.02 | EPS -4.0% · sales -100.0% | vs 2022Q1, year-ago quarter · EPS -11.1% · sales -100.0% | 6 | - |
| 2022Q4ended 2022-12-31 | 2023-03-14 16:30 | -0.960 | -1.165 | -0.986 | 0.00 | 0.00 | EPS -17.6% · sales - | vs 2021Q4, year-ago quarter · EPS -11.1% · sales -100.0% | 5 EPS · 4 sales | - |
Annual earnings
2025FY EPS -3.020 beat -3.210, from -3.660 a year earlier. Sales 30.91 beat 30.25, from 10.00 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | -0.161 | - | - | 557.2 | - |
| 2029FYestimate | - | -1.365 | - | - | 330.05 | - |
| 2028FYestimate | - | -2.098 | - | - | 213.31 | - |
| 2027FYestimate | - | -2.040 | - | - | 146.02 | - |
| 2026FYestimate | - | -1.972 | - | - | 109.95 | - |
| 2025FY | -3.020 | -3.210 | -3.020 | 30.91 | 30.25 | - |
| 2024FY | -3.660 | -3.031 | -3.658 | 10.00 | 7.70 | - |
| 2023FY | -3.960 | -3.144 | -3.962 | 0.00 | 5.93 | - |
| 2022FY | -4.560 | -4.711 | -4.574 | 2.60 | 2.66 | - |
| 2021FY | -4.920 | -4.760 | -4.899 | 2.05 | 1.47 | - |
| 2020FY | -5.280 | -4.860 | -5.300 | 88.52 | 54.61 | - |
| 2019FY | -24.000 | -23.790 | -24.009 | 17.46 | 16.41 | - |
| 2018FY | -12.539 | -18.580 | -16.431 | 26.72 | 28.45 | - |
| 2017FY | -21.120 | -20.863 | -21.176 | 0.00 | 0.00 | - |
| 2016FY | -11.880 | -11.200 | -11.880 | 0.00 | 0.00 | - |
| 2015FY | -19.320 | -19.667 | -19.320 | 0.00 | 0.00 | - |
| 2014FY | -24.840 | -25.070 | -24.840 | 0.00 | 0.00 | - |
| 2013FY | -21.840 | -21.330 | -21.840 | 0.00 | 0.00 | - |
| 2012FY | -20.400 | -20.676 | -20.400 | 0.00 | 0.00 | - |
| 2011FY | -127.08 | -26.632 | -127.08 | 0.00 | 0.00 | - |
Quarterly results
2026Q3 revenue 24.01, from 11.24 a year earlier. Operating margin -313.29%, from -362.28% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026Q4 E -0.53 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026Q4 | E | per share | 2026-11-09 | -0.53 | +0.0% |
| 2026Q4 | R | per share | 2026-11-09 | -0.53 | +0.0% |
| 2026FY | E | per share | 2026-11-06 | -1.97 | +21.2% |
| 2026FY | R | per share | 2026-11-06 | -1.97 | +21.2% |
| 2026Q4 | S | per share | 2026-11-06 | 29.08 | -6.7% |
| 2026FY | S | - | 2026-11-06 | 109.95 | -3.1% |
| 2026Q3 | E | per share | 2026-10-28 | -0.47 | -2.7% |
| 2026Q3 | R | per share | 2026-10-28 | -0.47 | -2.7% |
| 2026Q3 | S | per share | 2026-10-26 | 26.57 | 0.0% |
| 2026Q2 | E | per share | 2026-08-04 | -0.43 | -2.0% |
| 2026Q2 | R | per share | 2026-08-04 | -0.43 | -2.0% |
| 2026Q2 | S | per share | 2026-08-04 | 22.88 | 0.0% |
| 2026Q1 | E | per share | 2026-04-28 | -0.47 | +0.9% |
| 2026Q1 | R | per share | 2026-04-28 | -0.47 | +0.9% |
| 2026Q1 | S | per share | 2026-04-28 | 21.43 | -1.9% |
| 2025FY | E | per share | 2026-02-28 | -3.21 | 0.0% |
| 2025Q4 | E | per share | 2026-02-28 | -0.52 | 0.0% |
| 2025FY | R | per share | 2026-02-28 | -3.21 | 0.0% |
| 2025Q4 | R | per share | 2026-02-28 | -0.52 | 0.0% |
| 2025FY | S | per share | 2026-02-28 | 30.25 | 0.0% |
| 2025Q4 | S | per share | 2026-02-28 | 16.90 | 0.0% |
| 2025Q3 | E | per share | 2025-10-28 | -0.62 | 0.0% |
| 2025Q3 | R | per share | 2025-10-28 | -0.62 | 0.0% |
| 2025Q3 | S | per share | 2025-10-22 | 5.76 | 0.0% |
| 2025Q2 | S | per share | 2025-08-05 | 1.25 | 0.0% |
| 2025Q2 | E | per share | 2025-07-28 | -0.73 | -0.5% |
| 2025Q2 | R | per share | 2025-07-28 | -0.73 | -0.5% |
| 2025Q1 | S | per share | 2025-05-08 | 0.10 | -12.5% |
| 2025Q1 | E | per share | 2025-05-07 | -0.70 | +0.5% |
| 2025Q1 | R | per share | 2025-05-07 | -0.70 | +0.5% |
| 2024FY | E | per share | 2025-03-18 | -2.95 | -2.7% |
| 2024Q4 | E | per share | 2025-03-18 | -0.79 | -4.2% |
| 2024FY | R | per share | 2025-03-18 | -2.95 | -2.7% |
| 2024Q4 | R | per share | 2025-03-18 | -0.79 | -4.2% |
| 2024FY | S | per share | 2025-03-18 | 7.50 | -2.6% |
| 2024Q4 | S | per share | 2025-03-18 | 0.00 | -100.0% |
| 2024Q3 | E | per share | 2024-11-02 | -0.74 | 0.0% |
| 2024Q3 | R | per share | 2024-11-02 | -0.74 | 0.0% |
| 2024Q3 | S | per share | 2024-10-16 | 0.06 | - |
| 2024Q2 | E | per share | 2024-07-30 | -0.96 | -5.3% |
| 2024Q2 | R | per share | 2024-07-30 | -0.96 | -5.3% |
| 2024Q2 | S | per share | 2024-05-10 | 0.07 | - |
| 2024Q1 | E | per share | 2024-03-25 | -1.03 | -3.5% |
| 2024Q1 | R | per share | 2024-03-25 | -1.03 | -3.5% |
| 2024Q1 | S | per share | 2024-03-25 | 0.00 | - |
| 2023FY | E | per share | 2024-02-14 | -3.14 | -2.4% |
| 2023FY | R | per share | 2024-02-14 | -3.14 | -2.4% |
| 2023FY | S | per share | 2024-02-14 | 5.93 | +16.7% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -21.176 | -16.431 | -24.009 | -5.3 | -4.899 | -4.574 | -3.962 | -3.658 | -3.022 | -1.8514 | - |
| Sales USD millions | 0 | 27 | 17 | 19 | 1 | 0 | 0 | 10 | 31 | 100 | - |
| Shares million shares | 4 | 6 | 7 | 14 | 15 | 17 | 25 | 45 | 78 | - | 94 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.595 | -1.325 | -0.962 | -0.625 | -1.347 | -0.395 | -0.372 | -0.346 | -0.738 |
| Sales USD millions | 0 | 0 | 0 | 2 | 11 | 18 | 19 | 40 | 24 |
| Shares million shares | 40 | 45 | 51 | 62 | 67 | 78 | 88 | 90 | 94 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 100.30 | 30.91+209.1% | 10.00 | 0.00 | 0.00-100.0% | 0.61-96.7% | 18.52+6.1% | 17.46-34.7% | 26.72 |
| Cost of Goods Sold Incl. D&A | 13.93 | 5.30+17566.7% | 0.03-50.0% | 0.06-50.0% | 0.12-42.9% | 0.21-93.2% | 3.09-4.6% | 3.24+105.1% | 1.58 |
| Gross Profit | 86.37 | 25.62+157.0% | 9.97 | -0.06 | -0.12-130.0% | 0.40-97.4% | 15.43+8.5% | 14.22-43.4% | 25.13 |
| Selling, General and Administrative Excl. Other | 280.67 | 195.75+56.7% | 124.93+35.8% | 92.02+22.0% | 75.42+19.2% | 63.26-36.0% | 98.82-32.6% | 146.56+22.2% | 119.92 |
| Research and Development | 180.04 | 114.60+40.9% | 81.33+32.5% | 61.36+21.4% | 50.56+28.5% | 39.35-3.7% | 40.88-10.7% | 45.78+4.9% | 43.65 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -194.31 | -170.13 | -114.96 | -92.08 | -75.53 | -62.86 | -83.39 | -132.34 | -94.78 |
| Interest Expense | 1.37 | 1.14-75.0% | 4.56+10.1% | 4.14+93.5% | 2.14-78.5% | 9.97-36.9% | 15.79-23.4% | 20.61+254.7% | 5.81 |
| Unusual Expense | -13.50 | 42.07+181.2% | 14.96 | -2.75 | 0.00 | 0.00-100.0% | 6.36 | - | - |
| Net Income Before Taxes | -178.09 | -209.47 | -130.45 | -87.37 | -73.81 | -71.20 | -67.53 | -149.21 | -72.43 |
| Income Taxes | 0.82 | 0.00-100.0% | 0.18 | 0.00 | 0.00 | 0.00-100.0% | 0.19 | 0.00 | 0.00 |
| Consolidated Net Income | -178.90 | -209.47 | -130.64 | -87.37 | -73.81 | -71.20 | -67.73 | -149.21 | -72.43 |
| Net Income From Continuing Operations | -178.90 | -209.47 | -130.64 | -87.37 | -73.81 | -71.20 | -67.73 | -149.21 | -72.43 |
| Net Income | -178.90 | -209.47 | -130.64 | -87.37 | -73.81 | -71.20 | -67.73 | -149.21 | -72.43 |
| EPS (Recurring) per share | -1.86 | -2.60 | -3.36 | -4.05 | -4.57 | -4.90 | -4.95 | -24.01 | -16.43 |
| EPS (Basic, Before Extraordinaries) per share | -1.85 | -3.02 | -3.66 | -3.96 | -4.57 | -4.90 | -5.30 | -24.01 | -13.38 |
| EPS (Diluted) per share | -1.85 | -3.02 | -3.66 | -3.96 | -4.57 | -4.90 | -5.30 | -24.01 | -16.43 |
| EBITDA | -193.17 | -169.40 | -114.93 | -92.02 | -75.42 | -62.65 | -82.07 | -130.34 | -93.36 |
| Non-Operating Income (Expense) | 4.09 | 3.87-4.0% | 4.03-34.0% | 6.11+58.3% | 3.86+136.8% | 1.63-95.7% | 38.02+916.6% | 3.74-86.7% | 28.16 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 9.71 | 9.40+62.1% | 5.80-1.0% | 5.86-3.1% | 6.05-21.5% | 7.71+30.0% | 5.93-30.6% | 8.54+28.0% | 6.67 |
| Price To Sales Ratio ratio | 8.13 | 17.31 | 18.46 | - | - | 589.99 | 17.64 | 5.72 | 8.72 |
| Gross Margin % | 86.11 | 82.86 | 99.74 | - | - | 66.01 | 83.32 | 81.46 | 94.07 |
| Operating Margin % | -193.73 | -550.33 | -1,149.56 | - | - | -10,372.28 | -450.38 | -758.14 | -354.75 |
| Net Margin % | -178.38 | -677.59 | -1,306.37 | - | - | -11,749.17 | -365.77 | -854.77 | -271.11 |
| Shares Outstanding million shares | 94.47 | 77.74+73.6% | 44.78+77.1% | 25.28+51.3% | 16.71+8.2% | 15.44+8.7% | 14.20+112.6% | 6.68+8.6% | 6.15 |
| Market Capitalization | 1,063.57 | 1,063.57+362.2% | 230.10+11.9% | 205.68+143.2% | 84.56-77.7% | 379.84+4.6% | 363.07+238.2% | 107.36-56.7% | 247.99 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 24.01+113.6% | 40.08+1772.9% | 18.67 | 17.54 | 11.24 | 2.14-78.6% | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 3.94+101.0% | 4.04+608.8% | 3.05+30400.0% | 2.89+28800.0% | 1.96+19500.0% | 0.57+5600.0% | 0.010.0% | 0.010.0% |
| Gross Profit | 20.07+116.3% | 36.04+2210.3% | 15.62 | 14.64 | 9.28 | 1.56-84.4% | -0.01 | -0.01 |
| Selling, General and Administrative Excl. Other | 95.29+90.6% | 68.75+51.7% | 60.52+37.0% | 56.12+77.7% | 50.00+35.1% | 45.33+60.3% | 44.16+57.4% | 31.58+1.4% |
| Research and Development | 68.81+137.4% | 41.34+66.8% | 38.22+31.1% | 31.68+52.2% | 28.99+17.1% | 24.79+37.3% | 29.15+64.6% | 20.81-7.5% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -75.22 | -32.71 | -44.90 | -41.47 | -40.72 | -43.76 | -44.17 | -31.59 |
| Interest Expense | 0.21-34.4% | 0.36+71.4% | 0.38+100.0% | 0.41-64.3% | 0.32-72.2% | 0.21-81.6% | 0.19-83.2% | 1.15+2.7% |
| Unusual Expense | -0.00-100.0% | 1.84 | -7.45-186.0% | -7.89-124.2% | 58.63 | -17.33 | 8.66+44.1% | 32.61 |
| Net Income Before Taxes | -74.72 | -33.86 | -36.59 | -32.92 | -98.52 | -25.93 | -52.10 | -64.36 |
| Income Taxes | 0.00 | 0.82 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.18 |
| Consolidated Net Income | -74.72 | -34.67 | -36.59 | -32.92 | -98.52 | -25.93 | -52.10 | -64.55 |
| Net Income From Continuing Operations | -74.72 | -34.67 | -36.59 | -32.92 | -98.52 | -25.93 | -52.10 | -64.55 |
| Net Income | -74.72 | -34.67 | -36.59 | -32.92 | -98.52 | -25.93 | -52.10 | -64.55 |
| EPS (Recurring) per share | -0.74 | -0.33 | -0.43 | -0.46 | -0.79 | -0.79 | -0.85 | -0.86 |
| EPS (Basic, Before Extraordinaries) per share | -0.74 | -0.35 | -0.37 | -0.39 | -1.35 | -0.39 | -0.96 | -1.33 |
| EPS (Diluted) per share | -0.74 | -0.35 | -0.37 | -0.39 | -1.35 | -0.62 | -0.96 | -1.33 |
| EBITDA | -74.94 | -32.43 | -44.62 | -41.18 | -40.42 | -43.64 | -44.16 | -31.58 |
| Non-Operating Income (Expense) | 0.71-38.3% | 1.06+49.3% | 1.24+34.8% | 1.08+10.2% | 1.15+53.3% | 0.71-26.0% | 0.92-31.3% | 0.98-46.2% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 2.93+34.4% | 2.71-20.5% | 2.05+14.5% | 2.03+26.9% | 2.18+12.4% | 3.41+78.5% | 1.79+20.9% | 1.600.0% |
| Price To Sales Ratio ratio | 8.13 | 4.37 | 10.51 | 20.83 | 48.28 | 143.78 | 32.67 | 25.18 |
| Gross Margin % | 83.57 | 89.92 | 83.66 | 83.51 | 82.57 | 73.14 | - | - |
| Operating Margin % | -313.28 | -81.62 | -240.46 | -236.52 | -362.17 | -2,047.92 | - | - |
| Net Margin % | -311.19 | -86.51 | -195.98 | -187.72 | -876.34 | -1,213.57 | - | - |
| Shares Outstanding million shares | 94.47+41.5% | 90.48+47.1% | 87.84+70.6% | 77.74+73.6% | 66.75+65.8% | 61.52+128.9% | 51.49+103.4% | 44.78+77.1% |
| Market Capitalization | 1,063.57+95.7% | 335.68+47.2% | 465.53+49.9% | 581.47+152.7% | 543.45+351.6% | 228.04+202.2% | 310.46+4.0% | 230.10+11.9% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 204.99+130.8% | 88.82-35.7% | 138.06+57.1% | 87.89-12.3% | 100.26-29.0% | 141.23+87.0% | 75.51-69.8% | 250.39+188.4% | 86.83 |
| Short Term Receivables | 9.21+4505.0% | 0.20+400.0% | 0.04-69.2% | 0.13-81.9% | 0.72+200.0% | 0.24-90.5% | 2.52+712.9% | 0.31 | 0.00 |
| Inventories | 1.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 3.10+839.4% | 0.33 | 0.00 |
| Other Current Assets | 7.38+24.2% | 5.94+6.5% | 5.58+15.1% | 4.85+1.7% | 4.77+37.5% | 3.47-9.4% | 3.83+71.7% | 2.23+134.7% | 0.95 |
| Total Current Assets | 223.41+135.3% | 94.96-33.9% | 143.68+54.7% | 92.87-12.2% | 105.74-27.0% | 144.94+70.6% | 84.96-66.5% | 253.26+188.5% | 87.79 |
| Net Property, Plant & Equipment | 0.49-66.0% | 1.44+19.0% | 1.21-35.6% | 1.88-25.1% | 2.51-20.1% | 3.14-21.9% | 4.02+193.4% | 1.37+59.3% | 0.86 |
| Total Investments and Advances | 0.00-100.0% | 0.240.0% | 0.240.0% | 0.240.0% | 0.24-96.0% | 6.04-82.8% | 35.04 | 0.00 | 0.00 |
| Intangible Assets | 16.43 | - | - | - | - | 0.00-100.0% | 20.01-7.3% | 21.58 | 0.00 |
| Other Assets | 6.11+24.7% | 4.90+6.8% | 4.59+7550.0% | 0.06-64.7% | 0.17-26.1% | 0.23-77.2% | 1.01-1.9% | 1.03-9.6% | 1.14 |
| Total Assets | 246.44+142.7% | 101.54-32.2% | 149.72+57.5% | 95.05-12.5% | 108.66-29.6% | 154.35+6.4% | 145.05-47.7% | 277.24+208.8% | 89.79 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.84+489.9% | 0.99+5.3% | 0.94-12.1% | 1.07+59.7% | 0.67+19.6% | 0.56+33.3% | 0.42-92.7% | 5.72 | 0.00 |
| Accounts Payable | 12.45+208.9% | 4.03-43.9% | 7.18+46.5% | 4.90+113.0% | 2.30+22.3% | 1.88-80.5% | 9.65-5.9% | 10.25+11.5% | 9.19 |
| Other Current Liabilities | 53.98+108.0% | 25.95+42.2% | 18.25+16.3% | 15.69+0.4% | 15.62+6.5% | 14.66-26.0% | 19.82-6.1% | 21.11+165.9% | 7.94 |
| Total Current Liabilities | 72.27+133.4% | 30.97+17.4% | 26.38+21.8% | 21.66+16.5% | 18.59+8.8% | 17.09-42.8% | 29.89-19.4% | 37.08+116.5% | 17.13 |
| Long Term Debt | 81.33+97.1% | 41.26+1.6% | 40.62+56.2% | 26.00+935.9% | 2.51-88.6% | 21.98-79.5% | 107.11-6.6% | 114.74+673.7% | 14.83 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 35.65-38.7% | 58.20+1289.0% | 4.19 | 0.00 | 0.00 | 0.00-100.0% | 0.87-22.3% | 1.12+646.7% | 0.15 |
| Total Liabilities | 189.25+45.1% | 130.43+83.2% | 71.19+49.4% | 47.66+125.9% | 21.10-46.0% | 39.08-71.7% | 137.87-9.9% | 152.94+376.3% | 32.11 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00-100.0% | 21.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 57.20 | -28.89-150.4% | 57.37+21.1% | 47.39-45.9% | 87.56-24.0% | 115.27+1507.7% | 7.17-94.2% | 124.30+115.5% | 57.68 |
| Total Shareholders Equity | 57.20 | -28.89-136.8% | 78.53+65.7% | 47.39-45.9% | 87.56-24.0% | 115.27+1507.7% | 7.17-94.2% | 124.30+115.5% | 57.68 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 57.20 | -28.89-136.8% | 78.53+65.7% | 47.39-45.9% | 87.56-24.0% | 115.27+1507.7% | 7.17-94.2% | 124.30+115.5% | 57.68 |
| Total Liabilities & Stockholders Equity | 246.44+142.7% | 101.54-32.2% | 149.72+57.5% | 95.05-12.5% | 108.66-29.6% | 154.35+6.4% | 145.05-47.7% | 277.24+208.8% | 89.79 |
| Book Value Per Share per share | 0.74 | -0.65-128.6% | 2.27-20.1% | 2.84-49.9% | 5.67-30.2% | 8.12+658.9% | 1.07-94.7% | 20.21+48.3% | 13.63 |
| Tangible Book Value Per Share per share | 0.52 | -0.65-128.6% | 2.27-20.1% | 2.84-49.9% | 5.67-30.2% | 8.12 | -1.92-111.5% | 16.70+22.5% | 13.63 |
| Full-Time Employees people | 102+30.8% | 78+6.8% | 73+28.1% | 57+18.8% | 480.0% | 48-64.4% | 135-20.1% | 1690.0% | 169 |
| Price to Book Ratio ratio | 78.94 | 18.82 | 2.47 | 1.34 | 4.34 | 3.15 | 14.96 | 2.00 | 2.99 |
| Return on Assets % | -120.39 | -103.99 | -71.39 | -72.47 | -54.14 | -45.24 | -70.67 | -39.47 | -78.19 |
| Return on Equity % | -1,480.15 | -526.34 | -138.76 | -109.39 | -70.21 | -110.62 | -226.98 | -79.61 | -104.33 |
| Return on Invested Capital % | -151.21 | -1,056.42 | -73.33 | -100.58 | -79.05 | -49.34 | -130.56 | -30.30 | -93.50 |
| Quick Ratio ratio | 3.07 | 3.07 | 5.45 | 4.29 | 5.69 | 8.48 | 2.74 | 6.82 | 5.13 |
| Current Ratio ratio | 3.09 | 3.07 | 5.45 | 4.29 | 5.69 | 8.48 | 2.84 | 6.83 | 5.13 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -178.90 | -209.47 | -130.64 | -87.37 | -73.81 | -71.20 | -67.73 | -149.21 | -72.43 |
| Depreciation | 1.14 | 0.73+2333.3% | 0.03-50.0% | 0.06-50.0% | 0.12-42.9% | 0.21-84.1% | 1.32-34.0% | 2.00+40.8% | 1.42 |
| Other Funds (Non Cash) | -9.72 | 45.23+104.5% | 22.12+1128.9% | 1.80-70.6% | 6.12-63.8% | 16.91-13.3% | 19.50+21.5% | 16.05 | -17.15 |
| Funds from Operations | -187.48 | -163.51 | -108.49 | -85.50 | -67.57 | -54.09 | -46.90 | -131.16 | -88.17 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 27.91 | 26.00+598.9% | 3.72 | -0.96-124.6% | 3.90+572.4% | 0.58-95.0% | 11.63 | -7.80-157.1% | 13.65 |
| Cash from Operating Activities | -159.57 | -137.51 | -104.77 | -86.46 | -63.67 | -53.50 | -35.27 | -138.96 | -74.52 |
| Capital Expenditures | -8.85 | -9.62 | -0.03 | 0.00 | 0.00 | -0.20 | -0.03 | -0.01 | -23.51 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.08 |
| Purchase or Sale of Investments | 0.23 | 0.00-100.0% | 60.00 | -44.45-167.2% | 66.19+23539.3% | 0.28 | -47.33-152.8% | 89.62 | -114.95 |
| Purchase of Investments | -16.02 | 0.00 | 0.00 | -96.45 | -17.82 | -86.44 | -79.38 | -94.12 | -125.45 |
| Sale Or Maturity of Investments | 16.25 | 0.00-100.0% | 60.00+15.4% | 52.00-38.1% | 84.00-3.1% | 86.72+170.6% | 32.05-82.6% | 183.74+1649.9% | 10.50 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -8.61 | -9.62-116.0% | 59.97 | -44.45-167.2% | 66.19+73444.4% | 0.09 | -47.36-152.9% | 89.61 | -138.38 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 157.21 | 230.88+320.3% | 54.93-54.1% | 119.58+332.6% | 27.64+253.9% | 7.81-92.8% | 109.04+19029.8% | 0.57-99.5% | 105.97 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 157.21 | 230.88+320.3% | 54.93-54.1% | 119.58+332.6% | 27.64+253.9% | 7.81-92.8% | 109.04+19029.8% | 0.57-99.5% | 105.97 |
| Proceedsfrom Stock Options | 156.93 | 230.77+322.0% | 54.69-54.2% | 119.52+337.0% | 27.35+307.0% | 6.72-93.7% | 106.06 | 0.00-100.0% | 105.16 |
| Issuance or Reduction of Debt, Net | 46.06 | 32.42 | -0.15-101.0% | 14.62-39.5% | 24.15 | 0.00 | -37.37 | -2.50-101.6% | 155.20 |
| Change in Long Term Debt | 46.06 | 32.42 | -0.15-101.0% | 14.62-39.5% | 24.15 | 0.00 | -37.37 | -2.50-101.6% | 155.20 |
| Issuance of Long Term Debt | 50.74 | 76.18+5760.0% | 1.30-92.0% | 16.35-32.3% | 24.15 | 0.00 | 0.00-100.0% | 9.67-93.8% | 155.20 |
| Reduction of Long Term Debt | -4.67 | -43.76 | -1.45 | -1.73 | 0.00 | 0.00 | -37.37 | -12.17 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.93 | -0.28 | -0.07 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.93 | -0.28 | -0.07 | 0.00 |
| Cash from Financing Activities | 203.28 | 263.31+380.7% | 54.78-59.2% | 134.19+159.2% | 51.78+652.6% | 6.88-90.4% | 71.39 | -2.00-100.8% | 261.16 |
| Net Change in Cash | 35.09 | 116.17+1064.0% | 9.98+203.3% | 3.29-93.9% | 54.30 | -46.53 | -11.24 | -51.35-206.4% | 48.27 |
| Free Cash Flow | -159.57 | -137.51 | -104.80 | -86.46 | -63.67 | -53.70 | -35.30 | -138.96 | -76.02 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 172.80+25.5% | 136.35-17.0% | 181.68+54.5% | 204.99+130.8% | 137.71+21.4% | 164.32+97.1% | 117.57+5.8% | 88.82-35.7% |
| Short Term Receivables | 10.07+45.5% | 29.07+1175.0% | 10.36+5080.0% | 9.21+4505.0% | 6.92+3360.0% | 2.28-78.9% | 0.20-13.0% | 0.20+400.0% |
| Inventories | 2.25+25.7% | 2.40+105.1% | 2.29 | 1.83 | 1.79 | 1.17 | 0.00 | 0.00 |
| Other Current Assets | 14.25+86.5% | 8.33+28.0% | 8.58+23.8% | 7.38+24.2% | 7.64+8.4% | 6.51+19.4% | 6.93+10.2% | 5.94+6.5% |
| Total Current Assets | 199.38+29.4% | 176.16+1.1% | 202.90+62.7% | 223.41+135.3% | 154.06+27.7% | 174.27+74.9% | 124.70+6.0% | 94.96-33.9% |
| Net Property, Plant & Equipment | 2.46+228.0% | 2.62+167.3% | 2.79+130.6% | 0.49-66.0% | 0.75+13.6% | 0.98+14.0% | 1.21+15.2% | 1.44+19.0% |
| Total Investments and Advances | 0.24 | 0.24 | 0.240.0% | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.240.0% | 0.240.0% |
| Intangible Assets | 15.59-6.6% | 15.87+1.5% | 16.15 | 16.43 | 16.70 | 15.64 | - | - |
| Other Assets | 11.98+124.3% | 11.62+116.4% | 5.72+3.1% | 6.11+24.7% | 5.34+5.7% | 5.37+7.4% | 5.55+21.2% | 4.90+6.8% |
| Total Assets | 229.64+29.9% | 206.51+5.2% | 227.81+73.0% | 246.44+142.7% | 176.85+39.9% | 196.26+85.6% | 131.70+6.6% | 101.54-32.2% |
| Short Term Debt Incl. Current Port. of LT Debt | 12.35+142.2% | 5.93+41.9% | 6.29+107.6% | 5.84+489.9% | 5.10-52.7% | 4.18-35.4% | 3.03+60.3% | 0.99+5.3% |
| Accounts Payable | 20.23+104.6% | 18.00+123.6% | 9.60+33.3% | 12.45+208.9% | 9.89+122.7% | 8.05+20.5% | 7.20-3.4% | 4.03-43.9% |
| Other Current Liabilities | 70.75+58.2% | 54.20+42.1% | 50.95+100.7% | 53.98+108.0% | 44.72+101.9% | 38.14+121.7% | 25.39+46.1% | 25.95+42.2% |
| Total Current Liabilities | 103.33+73.1% | 78.13+55.1% | 66.84+87.6% | 72.27+133.4% | 59.71+59.8% | 50.36+65.9% | 35.62+33.3% | 30.97+17.4% |
| Long Term Debt | 116.21+37.7% | 78.39-2.7% | 79.19+7.3% | 81.33+97.1% | 84.37+175.3% | 80.54+127.6% | 73.77+45.8% | 41.26+1.6% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 35.65-38.7% | 48.29+84.7% | 29.31 | 54.75 | 58.20+1289.0% |
| Total Liabilities | 219.54+14.1% | 156.53-2.3% | 146.03-11.0% | 189.25+45.1% | 192.38+104.3% | 160.21+143.7% | 164.13+112.3% | 130.43+83.2% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Common Equity | 10.10 | 49.99+38.6% | 81.78 | 57.20 | -15.53-240.4% | 36.06+91.3% | -32.43-229.4% | -28.89-150.4% |
| Total Shareholders Equity | 10.10 | 49.99+38.6% | 81.78 | 57.20 | -15.53-148.2% | 36.06-9.9% | -32.43-170.2% | -28.89-136.8% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 10.10 | 49.99+38.6% | 81.78 | 57.20 | -15.53-148.2% | 36.06-9.9% | -32.43-170.2% | -28.89-136.8% |
| Total Liabilities & Stockholders Equity | 229.64+29.9% | 206.51+5.2% | 227.81+73.0% | 246.44+142.7% | 176.85+39.9% | 196.26+85.6% | 131.70+6.6% | 101.54-32.2% |
| Book Value Per Share per share | 0.11 | 0.55-6.8% | 0.93 | 0.74 | -0.23-185.2% | 0.59-15.7% | -0.63-163.6% | -0.65-128.6% |
| Tangible Book Value Per Share per share | -0.06 | 0.38+15.2% | 0.75 | 0.52 | -0.48-277.8% | 0.33-52.9% | -0.63-163.6% | -0.65-128.6% |
| Full-Time Employees people | - | - | - | 102+30.8% | - | - | - | 78+6.8% |
| Price to Book Ratio ratio | 78.94 | 4.10 | 7.20 | -33.19 | 15.07 | -6.59 | -9.35 | 18.82 |
| Return on Assets % | -88.02 | -100.65 | -107.90 | -120.39 | -159.02 | -110.30 | -116.66 | -103.99 |
| Return on Equity % | - | -471.16 | -786.15 | -1,480.15 | -2,888.70 | -437.92 | -2,159.50 | -526.33 |
| Return on Invested Capital % | -59.16 | -27.01 | -22.73 | -23.76 | -143.09 | -22.24 | -126.06 | -522.00 |
| Quick Ratio ratio | 1.91 | 2.22 | 3.00 | 3.07 | 2.55 | 3.44 | 3.50 | 3.07 |
| Current Ratio ratio | 1.93 | 2.25 | 3.04 | 3.09 | 2.58 | 3.46 | 3.50 | 3.07 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -74.72 | -34.67 | -36.59 | -32.92 | -98.52 | -25.93 | -52.10 | -64.55 |
| Depreciation | 0.28-3.4% | 0.28+115.4% | 0.28+2700.0% | 0.30+2900.0% | 0.29+2800.0% | 0.13+1200.0% | 0.010.0% | 0.010.0% |
| Other Funds (Non Cash) | 1.75-97.0% | 3.36 | -7.24-179.1% | -7.59-121.8% | 59.15 | -15.48 | 9.15+30.2% | 34.80 |
| Funds from Operations | -72.69 | -31.04 | -43.55 | -40.21 | -39.08 | -41.28 | -42.94 | -29.74 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 39.10+1267.1% | -12.87-249.3% | -8.57-301.2% | 10.25+120.9% | 2.86-75.2% | 8.62 | 4.26 | 4.64+11500.0% |
| Cash from Operating Activities | -33.59 | -43.91 | -52.12 | -29.95 | -36.22 | -32.66 | -38.68 | -25.10 |
| Capital Expenditures | -7.50 | 0.00 | 0.00 | -1.34 | -8.28 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 16.25 | -16.02 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Purchase of Investments | 0.00 | 0.00 | -16.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 16.25 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -7.50 | 16.25 | -16.02 | -1.34 | -8.28 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 29.00+59.7% | 0.03-100.0% | 29.41-14.2% | 98.77+11123.9% | 18.16-66.3% | 79.69+56821.4% | 34.27+37977.8% | 0.88 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 29.00+59.7% | 0.03-100.0% | 29.41-14.2% | 98.77+11123.9% | 18.16-66.3% | 79.69+56821.4% | 34.27+37977.8% | 0.88 |
| Proceedsfrom Stock Options | 28.80+59.3% | 0.00-100.0% | 29.37-14.2% | 98.75+144.0% | 18.08+27.1% | 79.69 | 34.24 | 40.47 |
| Issuance or Reduction of Debt, Net | 48.54 | -1.56 | -0.72-102.2% | -0.19 | -0.28 | -0.27 | 33.16+3544.0% | -0.13 |
| Change in Long Term Debt | 48.54 | -1.56 | -0.72-102.2% | -0.19 | -0.28 | -0.27 | 33.16+3544.0% | -0.13 |
| Issuance of Long Term Debt | 50.00 | 0.00 | 0.74-99.0% | 0.00 | 0.00 | 0.00 | 76.18+5760.0% | 0.00 |
| Reduction of Long Term Debt | -1.46 | -1.56 | -1.46 | -0.19 | -0.28 | -0.27 | -43.02 | -0.13 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 77.54+333.7% | -1.54-101.9% | 28.69-57.5% | 98.58+13221.6% | 17.88-66.6% | 79.42 | 67.43+7832.9% | 0.74 |
| Net Change in Cash | 36.45 | -29.20-162.5% | -39.44-237.2% | 67.28 | -26.62-189.3% | 46.75+4483.3% | 28.75+716.8% | -24.36 |
| Free Cash Flow | -33.59 | -43.91 | -52.12 | -29.95 | -36.22 | -32.66 | -38.68 | -25.10 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Product revenue, net | - | 30.91 | - | 100.0% |
| Sale of COPIKTRA license and related assets | 10.00 | - | - | - |
| Total | 10.00 | 30.91 | +209.1% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 10.00 | 30.91 | +209.1% | 100.0% |
| Total | 10.00 | 30.91 | +209.1% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 17.24% | 19.7M | 114.1M | 3.27M |
| 2026-10-15 | 15.64% | 17.2M | 110.0M | 2.99M |
| 2026-09-30 | 18.30% | 15.0M | 81.8M | 2.28M |
| 2026-09-15 | 22.05% | 18.0M | 81.8M | 2.49M |
| 2026-08-31 | 22.38% | 18.3M | 81.8M | 2.44M |
| 2026-08-14 | 23.13% | 18.9M | 81.8M | 2.52M |
| 2026-07-31 | 23.73% | 19.8M | 83.5M | 2.62M |
| 2026-07-15 | 25.34% | 20.1M | 79.3M | 2.61M |
| 2026-06-30 | 30.43% | 24.1M | 79.3M | 2.46M |
| 2026-06-15 | 27.46% | 21.8M | 79.3M | 2.33M |
| 2026-05-29 | 25.91% | 21.2M | 81.9M | 2.21M |
| 2026-05-15 | 21.73% | 17.9M | 82.2M | 2.10M |
| 2026-04-30 | 23.24% | 17.5M | 75.4M | 1.95M |
| 2026-04-15 | 23.11% | 17.4M | 75.4M | 1.89M |
| 2026-03-31 | 21.73% | 16.4M | 75.3M | 1.97M |
| 2026-03-13 | 23.70% | 17.9M | 75.3M | 1.79M |
| 2026-02-27 | 26.47% | 17.1M | 64.6M | 1.76M |
| 2026-02-13 | 27.95% | 18.1M | 64.6M | 2.01M |
| 2026-01-30 | 25.34% | 16.5M | 65.0M | 2.16M |
| 2026-01-15 | 26.24% | 17.1M | 65.2M | 2.34M |
Option chain
Expiry 2026-11-20 · underlying 8.35, quoted 13 Nov 07:45 ET · ATM 8.00
Option quotes 12 Nov 13:36 ET. A date on a row is older than the last session (12 Nov). 33 rows.
Implied move 24.55% into expiry (call 0.625 + put 1.425 = 2.050 on 8.35)
Put/call open interest 0.50 (1,285 puts / 2,578 calls) · Put/call volume 0.20 (17 puts / 83 calls)
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 9 Oct | 1.00 | ITM | 5.40 | 10.00 | 7.17 | 0.00 | - | 2 | 0 | 0 | 0.991 | -0.016 | 0.000 |
| put 1 Jan | OTM | 0.00 | 0.05 | 0.00 | 0.00 | - | 0 | 0 | 0 | -0.008 | -0.015 | 0.000 | |
| call 1 Jan | 2.00 | ITM | 4.40 | 9.00 | 0.00 | 0.00 | 0.0% -646.3 | 0 | 0 | 0 | 0.977 | -0.028 | 0.001 |
| put 1 Jan | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 646.2% 0.0 | 0 | 0 | 0 | -0.023 | -0.028 | 0.001 | |
| call 14 Oct | 3.00 | ITM | 3.80 | 8.00 | 5.90 | 0.00 | 2312.0% +1838.0 | 6 | 0 | 0 | 0.967 | -0.028 | 0.001 |
| put 1 Jan | OTM | 0.00 | 0.10 | 0.00 | 0.00 | 628.3% 0.0 | 0 | 0 | 0 | -0.052 | -0.054 | 0.002 | |
| call 1 Jan | 4.00 | ITM | 2.50 | 7.00 | 0.00 | 0.00 | 1551.9% +1124.4 | 0 | 0 | 0 | 0.934 | -0.044 | 0.002 |
| put 14 Oct | OTM | 0.00 | 0.75 | 0.05 | 0.00 | 427.5% 0.0 | 20 | 0 | 0 | -0.066 | -0.043 | 0.002 | |
| call 9 Nov | 5.00 | ITM | 1.45 | 6.00 | 3.82 | 0.00 | 1188.5% +843.1 | 1 | 0 | 0 | 0.901 | -0.048 | 0.002 |
| put 6 Nov | OTM | 0.00 | 0.75 | 0.05 | 0.00 | 345.4% 0.0 | 62 | 0 | 0 | -0.099 | -0.047 | 0.002 | |
| call 9 Nov | 6.00 | ITM | 0.60 | 4.90 | 2.65 | 0.00 | 911.8% +659.2 | 5 | 0 | 0 | 0.866 | -0.043 | 0.003 |
| put 6 Nov | OTM | 0.00 | 0.75 | 0.05 | 0.00 | 252.6% 0.0 | 21 | 0 | 0 | -0.134 | -0.043 | 0.003 | |
| call 20 Oct | 7.00 | ITM | 0.00 | 4.10 | 2.45 | 0.00 | 780.4% +609.7 | 51 | 0 | 0 | 0.810 | -0.037 | 0.003 |
| put | OTM | 0.00 | 0.25 | 0.05 | 0.00 | 106.5% 0.0 | 207 | 10 | 10 | -0.077 | -0.012 | 0.002 | |
| call 11 Nov | 8.00 | ATM | 0.00 | 1.25 | 1.30 | 0.00 | 211.4% -156.3 | 128 | 0 | 0 | 0.644 | -0.108 | 0.005 |
| put | ATM | 0.05 | 2.80 | 0.20 | +0.05 | 415.7% +48.1 | 411 | 5 | 5 | -0.356 | -0.108 | 0.005 | |
| call | 9.00 | OTM | 0.00 | 0.60 | 0.30 | -0.15 | 166.9% -21.0 | 1,383 | 82 | 1 | 0.463 | -0.059 | 0.005 |
| put 11 Nov | ITM | 0.00 | 1.75 | 0.40 | 0.00 | 288.3% +100.4 | 456 | 0 | 0 | -0.537 | -0.058 | 0.005 | |
| call 11 Nov | 10.00 | OTM | 0.05 | 0.25 | 0.20 | 0.00 | 148.6% 0.0 | 693 | 0 | 0 | 0.253 | -0.038 | 0.004 |
| put 29 Oct | ITM | 0.10 | 4.20 | 1.10 | 0.00 | 160.6% +12.1 | 107 | 0 | 0 | -0.747 | -0.037 | 0.004 | |
| call | 11.00 | OTM | 0.00 | 0.25 | 0.05 | 0.00 | 143.2% 0.0 | 291 | 1 | 1 | 0.124 | -0.023 | 0.003 |
| put 1 Jan | ITM | 0.05 | 4.90 | 0.00 | 0.00 | 638.3% +495.1 | 0 | 0 | 0 | -0.876 | -0.022 | 0.003 | |
| call 27 Oct | 12.00 | OTM | 0.00 | 0.75 | 0.31 | 0.00 | 174.8% 0.0 | 9 | 0 | 0 | 0.107 | -0.025 | 0.002 |
| put | ITM | 1.00 | 4.90 | 3.35 | 0.00 | 478.4% +303.7 | 1 | 2 | 1 | -0.893 | -0.024 | 0.002 | |
| call 1 Jan | 13.00 | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 202.3% 0.0 | 0 | 0 | 0 | 0.096 | -0.027 | 0.002 |
| put 1 Jan | ITM | 2.20 | 6.80 | 0.00 | 0.00 | 699.6% +497.3 | 0 | 0 | 0 | -0.904 | -0.026 | 0.002 | |
| call 26 Oct | 14.00 | OTM | 0.00 | 2.55 | 0.10 | 0.00 | 226.8% 0.0 | 6 | 0 | 0 | 0.088 | -0.029 | 0.002 |
| put 1 Jan | ITM | 3.00 | 7.10 | 0.00 | 0.00 | 591.1% +364.3 | 0 | 0 | 0 | -0.912 | -0.027 | 0.002 | |
| call 26 Oct | 15.00 | OTM | 0.00 | 2.55 | 0.05 | 0.00 | 248.9% 0.0 | 3 | 0 | 0 | 0.082 | -0.030 | 0.002 |
| put 1 Jan | ITM | 4.00 | 8.60 | 0.00 | 0.00 | 723.2% +474.3 | 0 | 0 | 0 | -0.918 | -0.028 | 0.002 | |
| call 1 Jan | 16.00 | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 269.1% 0.0 | 0 | 0 | 0 | 0.077 | -0.031 | 0.002 |
| put 1 Jan | ITM | 5.00 | 9.50 | 0.00 | 0.00 | 730.6% +461.6 | 0 | 0 | 0 | -0.923 | -0.029 | 0.002 | |
| call 1 Jan | 17.00 | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 287.6% 0.0 | 0 | 0 | 0 | 0.074 | -0.032 | 0.002 |
| put 1 Jan | ITM | 6.00 | 10.60 | 0.00 | 0.00 | 776.0% +488.5 | 0 | 0 | 0 | -0.926 | -0.030 | 0.002 | |
| call 1 Jan | 18.00 | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 304.7% 0.0 | 0 | 0 | 0 | 0.071 | -0.033 | 0.002 |
| put 1 Jan | ITM | 7.00 | 11.50 | 0.00 | 0.00 | 779.0% +474.3 | 0 | 0 | 0 | -0.929 | -0.031 | 0.002 | |
| call 1 Jan | 19.00 | OTM | 0.00 | 2.55 | 0.00 | 0.00 | 320.6% 0.0 | 0 | 0 | 0 | 0.068 | -0.033 | 0.002 |
| put 1 Jan | ITM | 8.00 | 12.50 | 0.00 | 0.00 | 800.3% +479.8 | 0 | 0 | 0 | -0.932 | -0.031 | 0.002 |
Latest SEC filings
30 of 804AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-05, period ended 2026-09-30. 10-K filed 2026-03-04, period ended 2025-12-31. VSTM on EDGAR
page 1 of 27Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-10 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0000093751-26-000741 index |
| 2026-11-05 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-03 · transaction | 0001104659-26-123510 index |
| 2026-11-05 | S-3ASR | Registration statements and prospectuses | no report period | 0001104659-26-123460 index |
| 2026-11-05 | S-8 | Registration statements and prospectuses | no report period | 0001104659-26-123388 index |
| 2026-11-05 | 8-K | All annual, quarterly, and current reports | 2026-11-05 | 0001104659-26-123386 index |
| 2026-11-05 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001104659-26-123305 index |
| 2026-10-30 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002100119-26-001688 index |
| 2026-10-14 | 8-K | All annual, quarterly, and current reports | 2026-10-14 | 0001104659-26-115880 index |
| 2026-10-14 | 424B5 | Registration statements and prospectuses | no report period | 0001104659-26-115879 index |
| 2026-10-14 | 424B5 | Registration statements and prospectuses | no report period | 0001104659-26-115875 index |
| 2026-10-14 | 8-K | All annual, quarterly, and current reports | 2026-10-12 | 0001104659-26-115687 index |
| 2026-10-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-30 · transaction | 0001104659-26-113362 index |
| 2026-10-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-30 · transaction | 0001104659-26-113361 index |
| 2026-10-01 | 144 | no category | no report period | 0001104659-26-112933 index |
| 2026-09-23 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-21 · transaction | 0001104659-26-110070 index |
| 2026-08-14 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0001172661-26-003623 index |
| 2026-08-07 | 8-K | All annual, quarterly, and current reports | 2026-08-06 | 0001104659-26-092216 index |
| 2026-08-07 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0000093751-26-000555 index |
| 2026-08-06 | 8-K | All annual, quarterly, and current reports | 2026-08-06 | 0001104659-26-092058 index |
| 2026-08-06 | 10-Q | All annual, quarterly, and current reports | 2026-06-30 | 0001104659-26-092007 index |
| 2026-08-05 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-03 · transaction | 0001104659-26-091172 index |
| 2026-07-31 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0002100119-26-001480 index |
| 2026-07-30 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002012383-26-003122 index |
| 2026-07-23 | 144 | no category | no report period | 0001974158-26-000089 index |
| 2026-07-08 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0001172661-26-002511 index |
| 2026-06-25 | 144 | no category | no report period | 0001974158-26-000075 index |
| 2026-06-24 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-22 · transaction | 0001104659-26-077333 index |
| 2026-06-24 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-22 · transaction | 0001104659-26-077332 index |
| 2026-06-23 | 8-K | All annual, quarterly, and current reports | 2026-06-23 | 0001104659-26-076809 index |
| 2026-06-22 | 144 | no category | no report period | 0001104659-26-076543 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 12.47K | 1 |
| 2026-10 | 0 | 0 | 373.50K | 2 |
| 2026-09 | 0 | 0 | 424 | 1 |
| 2026-08 | 0 | 0 | 7.56K | 1 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 104.33K | 2 |
| 2026-05 | 0 | 0 | 4.69K | 1 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 6.49K | 1 |
| 2026-01 | 0 | 0 | 109.98K | 2 |
| 2025-12 | 0 | 0 | 196.50K | 13 |
| 2025-11 | 0 | 0 | 282.37K | 8 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 10.46% |
| Nantahala Capital Management, LLC | 8.16% |
| ARMISTICE CAPITAL, LLC | 7.99% |
| RTW INVESTMENTS, LP | 7.55% |
| Deep Track Capital, LP | 6.53% |
| Rosalind Advisors, Inc. | 4.54% |
| STATE STREET CORP | 4.44% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.38% |
| Stonepine Capital Management, LLC | 3.81% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.72% |
Funds
| Fund | % owned |
|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 3.86% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.20% |
| iShares Russell 2000 ETF | 2.35% |
| VANGUARD EXPLORER FUND | 1.59% |
| VANGUARD EXTENDED MARKET INDEX FUND | 1.09% |
| Fidelity Small Cap Index Fund | 0.99% |
| BlackRock Advantage Small Cap Core Fund | 0.90% |
| iShares Russell 2000 Growth ETF | 0.85% |
| Fidelity Enhanced Small Cap Core ETF | 0.66% |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | 0.61% |
OakChart. VSTM. Cached 15 minutes. Terms